Having found a link between dry eye and chronic pain syndromes, researchers suggest a multidisciplinary approach to treatment be undertaken.In a study of 154 patients with dry eye from the Miami Veterans Affairs Hospital, higher levels of pain, both oc…
Roche files direct de novo application to FDA for Anti-Mullerian assay
Roche announced today that it has filed a direct de novo application to the U.S. Food and Drug Administration for a fully automated Anti-Mullerian (AMH) assay for use on Roche’s full portfolio of laboratory analyzers. The determination of AMH is useful…
Scientists identify variations in the AIPL1 gene that cause Leber congenital amaurosis
The results are a vital step towards gene therapy for a devastating cause of severe sight loss in early childhood. Leading charities Fight for Sight and RP Fighting Blindness co-funded the research.
XL-Protein and Easton Pharmaceutical Sign License Agreement to Develop Biopharmaceuticals Using PASylation® Technology
FREISING, Germany & CHENGDU, China–(BUSINESS WIRE)–XL-protein and Easton Pharmaceutical Sign License Agreement to Develop Biopharmaceuticals Using PASylation® Technology
ALPHAEON completes acquisition of LENSAR
ALPHAEON Corporation, a social commerce company and subsidiary to Strathspey Crown Holdings LLC, today announced it has closed on its acquisition of LENSAR, Inc., a leading global developer and manufacturer of Femtosecond Lasers Systems (FLS), through …
Samenvatting: NovaTears stabiliseert traanfilm en vermindert droogte bij mensen met keratoconjunctivis sicca door traanverdamping
HEIDELBERG, Duitsland–(BUSINESS WIRE)–NovaTears, de eerste commercieel verkrijgbare oogdruppel van Novaliq GmbH voor de behandeling van keratoconjunctivis sicca (droge ogen) als gevolg van traanverdamping, zorgt voor significante verbeteringen van vi…